Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.908 EUR | +0.89% | -5.51% | -11.88% |
Apr. 22 | Pharming Group to Buy Back EUR123 Million of Bonds due 2025 | MT |
Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
Sales 2024 * | 262M 279M | Sales 2025 * | 300M 320M | Capitalization | 606M 646M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.07M | Net income 2025 * | 14M 14.93M | EV / Sales 2024 * | 1.97 x |
Net cash position 2024 * | 90.86M 96.91M | Net cash position 2025 * | 119M 127M | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
-300
x | P/E ratio 2025 * |
40.9
x | Employees | 382 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Pharming Group N.V.
1 day | +1.94% | ||
1 week | -4.58% | ||
Current month | -9.96% | ||
1 month | -11.01% | ||
3 months | -18.88% | ||
6 months | -11.09% | ||
Current year | -11.01% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Director of Finance/CFO | 55 | 20-11-15 | |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.05% | 7 M€ | -.--% | - | |
0.02% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.908 | +0.89% | 2 511 781 |
24-04-22 | 0.9 | +2.16% | 6,570,354 |
24-04-19 | 0.881 | +1.50% | 8,926,686 |
24-04-18 | 0.868 | -9.63% | 37,599,270 |
24-04-17 | 0.9605 | -0.10% | 2,891,437 |
Real-time Euronext Amsterdam, April 23, 2024 at 05:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.01% | 645M | |
+25.46% | 659B | |
+25.96% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.32% | 215B | |
+7.84% | 210B | |
-6.09% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- PHARM Stock